Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$2.19M Sell
38,919
-12,163
-24% -$712K 0.46% 28
2016
Q3
$3.04M Buy
51,082
+2,237
+5% +$131K 0.64% 14
2016
Q2
$2.69M Buy
48,845
+7,101
+17% +$378K 0.54% 20
2016
Q1
$2.11M Buy
41,744
+739
+2% +$36.2K 0.43% 27
2015
Q4
$2.07M Sell
41,005
-863
-2% -$43.5K 0.42% 27
2015
Q3
$1.97M Buy
41,868
+765
+2% +$40.6K 0.44% 27
2015
Q2
$2.23M Sell
41,103
-892
-2% -$50K 0.44% 26
2015
Q1
$2.3M Sell
41,995
-8,934
-18% -$506K 0.45% 24
2014
Q4
$2.76M Buy
50,929
+290
+0.6% +$16.2K 0.55% 15
2014
Q3
$2.86M Sell
50,639
-332
-0.7% -$18.6K 0.56% 16
2014
Q2
$2.81M Buy
50,971
+692
+1% +$37.8K 0.51% 17
2014
Q1
$2.72M Sell
50,279
-5,158
-9% -$267K 0.53% 19
2013
Q4
$2.65M Buy
+55,437
New +$2.53M 0.53% 17

Other funds holding MRK

Kanaly Trust's MRK Position: Q4 2016 in Review

Kanaly Trust reduced its Merck (MRK) stake by 24% in Q4 2016, selling an estimated $712K and leaving 38,919 shares worth $2.19M. The position accounts for 0.46% of the portfolio, ranked #28.

Kanaly Trust first reported a position in MRK in Q4 2013 and has held it in 13 quarters since. The position peaked at $3.04M in Q3 2016. 1,912 funds tracked by Wall St. Rank hold MRK as of Q4 2016.

  • Kanaly Trust held 38,919 shares of Merck worth $2.19M as of Q4 2016.
  • Kanaly Trust sold 12,163 Merck shares in Q4 2016, an estimated $712K.
  • Merck made up 0.46% of Kanaly Trust's portfolio in Q4 2016, its #28 holding.
  • Kanaly Trust first reported a position in Merck in Q4 2013 and has held it in 13 quarters since.
  • Kanaly Trust's Merck position peaked at $3.04M in Q3 2016.
  • 1,912 funds tracked by Wall St. Rank held Merck as of Q4 2016.

Based on Kanaly Trust's 13F filing for Q4 2016, filed 23 Jan 2017.